Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Korea, Republiek van
  4. Korea Stock Exchange
  5. Seegene, Inc.
  6. Nieuws
  7. Andere talen
    A096530   KR7096530001

SEEGENE, INC.

(A096530)
  Rapport
slotkoers Korea Stock Exchange  -  30-09-2022
26800.00 KRW   -0.56%
16/08Seegene, Inc. Rapporteert Winstresultaten voor het Tweede Kwartaal en de Zes Maanden Geëindigd op 30 Juni, 2022
CI
29/06Seegene, Inc. baant de weg voor PCR-tests in plaatselijke klinieken met door de EU goedgekeurde multiplex-test en volledig geautomatiseerde PCR-oplossing
CI
29/06Seegene verkrijgt EU-goedkeuring voor zijn Allplex SARS-CoV-2/FluA/FluB/RSV Assay
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenFonds 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op SEEGENE, INC.
28/09Seegene, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares.
28/09Seegene, Inc. authorizes a Buyback Plan.
27/09Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on March 4, 2022.
27/09Seegene, Inc.'s Equity Buyback announced on March 4, 2022, has expired with 1,137,640 s..
16/08Seegene, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June..
12/08Seegene reports H1 2022 financial results
29/07Seegene unveils strategies for global expansion at 2022 AACC
19/07Seegene launches world's first In-life PCR campaign in Vietnam
01/07Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on March 4, 2022.
01/07Seegene Gets EU Approval for PCR Testing
29/06Seegene to pave way for PCR testing at local clinics with EU-approved multiplex test an..
29/06Seegene Obtains EU Approval for its Allplex SARS-CoV-2/FluA/FluB/RSV Assay
29/06Seegene, Inc. to Pave Way for PCR Testing At Local Clinics with EU-Approved Multiplex T..
28/06Seegene develops PCR test to detect monkeypox virus
28/06Seegene Inc. Develops PCR Test to Detect Monkeypox Virus
28/06Seegene Develops Diagnostic Reagent for Monkeypox Virus
25/05Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic
16/05Seegene, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
13/05Seegene reports first quarter 2022 financial results
26/04Seegene unveils world's first commercialized '3 Ct' PCR assay
26/04Seegene, Inc. Unveils World's First Commercialized '3 Ct' PCR Assay
06/04Seegene's Allplex™ RV Master Assay Receives Australian TGA Approval
17/03Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
04/03Seegene, Inc. announces an Equity Buyback for KRW 50,000 million worth of its shares.
04/03Seegene, Inc. authorizes a Buyback Plan.
02/03Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business
24/02Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era
24/02Seegene Inc. Unveils New Assay Optimized for On-Site Testing in 'Living with Covid-19' ..
17/02Seegene Announces Q4 and Full-Year 2021 Financial Results
10/02Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil
10/02Seegene Signs Supply Deal to Deliver 4 Million Covid-19 Tests to Brazil
19/01Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Ma..
19/01Seegene Inc. to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized f..
17/01Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely ..
17/01Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada's ..
17/01Seegene Inc. Announces Allplex Sars Cov-2 FluA/FluB/RSV Assay Approved Under Health Can..
12/01Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Devel..
09/01Transcript : Seegene, Inc. Presents at JPMorgan 40th Annual Healthcare Confer..
2021Seegene Airlifts 1.7 million COVID-19 Tests to Israel Battling the Omicron Variant by a..
2021Seegene Inc. Airlifts 1.7 Million COVID-19 Tests to Israel Battling the Omicron Variant..
2021Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealt..
2021Seegene Inc. Unveils Another Series of Diagnostic Test that Detects the Ever-Changing C..
2021Seegene's High Multiplex Pcr Assay Capable of Detecting New Omicron Variant
2021Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant
2021Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum
2021Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing
2021Seegene Opens New Subsidiary in Bogot?, Colombia, to Advance Regional COVID-19 Testing
2021Seegene, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
2021Seegene Inc. Announces Launch of STARlet-AIOS: All-..
2021Launch Of Seegene's Starlet-aios : All-in-One System Fulfills Critical Need for Fully Auto..
2021Seegene, Inc.'s Equity Buyback announced on March 9, 2021, has expired.
2021Seegene : Unveils Fully Automated Molecular Testing System at the 2021 AACC
2021Seegene Inc. Unveils Fully Automated Molecular Testing System At the 2021 AACC
2021Seegene : Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four C..
2021Seegene : Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY
2021Seegene Inc. Reports Earnings Results for the Second Quarter and First Half Ended June ..
2021Seegene : Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Vari..
2021Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Var..
2021Seegene : announces partnership with Bio-Rad to develop diagnostic testing products for th..
2021Seegene Announces Partnership with Bio-Rad to Develop Diagnostic Testing Products for t..
2021Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on March 9, 2021.
2021Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on March 9, 2021.
2021Bio-Rad Laboratories, Inc. Announces Partnership with Seegene for Molecular Diagnostic ..
2021Seegene : unveils "MOBILE STATION," for on-site routine testing at public-use facilities a..
2021Seegene Inc. Introduces its New Deployable Container Laboratory "Mobile Station", at th..
2021Seegene : reports solid results in the first quarter of 2021 with KRW 351.8 billion
2021Seegene : introduces an exclusive diagnostic system for diagnosing COVID-19 variants at EC..
2021Seegene, Inc. Introduces an Exclusive Diagnostic System for Diagnosing Covid-19 Variant..
2021Seegene : signs exclusive supply agreement with the Kuwaiti government
2021Seegene : reports solid results in the first quarter of 2021 with KRW 351.8 billion
2021Seegene Inc. Reports Earnings Results for the First Quarter of 2021
2021Seegene : Germany subsidiary supports the back-to-school initiative with its COVID-19 test..
2021Seegene : to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sa..
2021Seegene to Supply Covid-19 Diagnostic Tests Worth GBP 16 Million to Scotland
2021Seegene : Italy subsidiary secures public procurement for 7.15 million COVID-19 diagnostic..
2021Seegene : begins exporting its latest COVID-19 variant tests around the world to help cont..
2021Seegene Inc. Secures an Export Permit from South Korea's Ministry of Food and Drug Safe..
2021Seegene, Inc.(KOSDAQ:A096530) added to FTSE All-World Index
2021Seegene, Inc. announces an Equity Buyback for KRW 30,000 million worth of its shares.
2021Seegene, Inc. authorizes a Buyback Plan.
2021Seegene : Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recogni..
2021Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of Its Allplex..
2021Seegene : posts unprecedented Q4 and 2020 FY results; writes history by joining trillion-w..
2021Seegene Inc. Reports Preliminary Financial Results for the Fourth Quarter and the Fisca..
2021Seegene : saliva test for COVID-19 is just as effective as NPS test
2021++ Analysen des Tages von Dow Jones Newswires (12.02.2021) +++
2021Seegene : ANALYSE/Südkoreas Gewinnabschöpfungsidee als internationales Vorbild?
2021Seegene : develops world first COVID-19 variant test capable of identifying origins of vir..
2021Seegene Develops World First Covid-19 Variant Test Capable of Identifying Origins of Vi..
2021Seegene Inc. Advances Business in Latin America
2021Seegene : to advance business in Latin America in the New Year
2021Seegene's COVID-19 Test with Saliva Sample Collection Feature Now Available in Europe
2021Seegene : COVID-19 test with saliva sample collection feature now available in Europe
2021Seegene's Covid-19 Test with Saliva Sample Collection Feature Now Available in Europe
2020Seegene : COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe
2020Hyundai's U.S. Actions in Response to Coronavirus (COVID-19)
2020Seegene : introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with..
2020Seegene, Inc. Introduces A High-Throughput 8-Plex Test for Flu A, Flu B, RSV and Covid-..
2020Seegene : South Korean COVID-19 test kit maker Seegene posts second-quarter prof..
2020Seegene Allplex 2019-nCoV Assay (SARS-CoV-2) Gets Expanded FDA Emergency Use Authorizat..
Volgende evenement op SEEGENE, INC.